{
    "nct_id": "NCT03093844",
    "official_title": "Safety and Efficacy of Miltenyi CliniMACSÂ® CD34 Reagent System for Transplant Protocol Utilizing Haploidentical CD34+ Selected Cells Combined With Single Unit Umbilical Cord Blood Transplant for Treatment of High-risk Hematologic Disorders",
    "inclusion_criteria": "Inclusion Criteria - Recipient\n\n* Ages 18-80 years inclusive\n* Diagnosed with high risk hematologic disorders warranting stem cell transplant per institutional standard of care\n* Lack HLA-identical related donor\n* Availability of at least one HLA- haploidentical (i.e. => 5/10 and <= 8/10 HLA match) related donor (HLA-A, B, C, DR, and DQ loci) who is available to donate CD34+ cells.\n* Availability of at least one 4/6 HLA-matched (HLA-A, B, and DR loci) cord blood unit from the National Marrow Donor Program (NMDP). The cord blood unit must contain a minimum TNC (prior to thawing) of at least 2x107 cells per kilogram of recipient body weight\n* Ability to comprehend the nature of the treatment 6.2. Exclusion Criteria - Recipient (any of the following)\n* HLA identical (6/6) related donor available and readily accessible at time of transplantation evaluation\n* Any patient not meeting institutional standard guidelines for transplant eligibility\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
    "exclusion_criteria": "",
    "miscellaneous_criteria": ""
}